Status:
UNKNOWN
Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.
Lead Sponsor:
Shimaa Abdalla Ahmed
Conditions:
Peritoneal Carcinomatosis
Eligibility:
FEMALE
18-100 years
Brief Summary
pathologically proved ovarian cancer patients that underwent contrast enhanced abdomino-pelvic CT and diagnostic laparoscopy before cytoreductive surgery (CRS) will be included in the study. Calculati...
Detailed Description
we will search medical records of primary ovarian cancer patients underwent CT abdomen, laparoscopy followed by cytoreductive surgery to calculate peritoneal carcinomatosis extent by each modality. R...
Eligibility Criteria
Inclusion
- pathologically proved ovarian cancer patients underwent contrast enhanced abdominopelvic CT and diagnostic laparoscopy before cytoreductive surgery -
Exclusion
- recurrent ovarian cancer
- \-
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03798132
Start Date
January 1 2019
End Date
December 1 2020
Last Update
January 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 11517